Bufogenin

Star0

DB19835ExperimentalSmall molecule

Bufogenin is a small molecule drug. Bufogenin has a monoisotopic molecular weight of 384.23 Da.

Mechanism: Pharmacologically active on Vascular endothelial growth factor receptor 2, Sodium/potassium-transporting ATPase subunit alpha-1, and Sodium/Potassium Transporting ATPase
Curator reviewed
Formula / weight: C₂₄H₃₂O₄ · 384.516 g/mol (avg)
Code names: NSC-90783

Resolves to

Compound

UNII3K654P2M4JCAS465-39-4ChEMBLCHEMBL250172ChEBI31319

Structure

InChIKeyATLJNLYIJOCWJE-CWMZOUAVSA-NSMILES[H][C@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@H](C[C@H]5O[C@@]345)C3=COC(=O)C=C3)[C@@]1(C)CC[C@H](O)C2

Targets

P35968KDRP05023ATP1A1

What you can answer from here — as of September 21, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Bufogenin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account